Skip to main content

Table 2 Geometric mean of EPG for Capillaria spp. at each time point and percent of reduction at each time point

From: Efficacy of milbemycin oxime/afoxolaner chewable tablets (NEXGARD SPECTRA®) against Capillaria aerophila and Capillaria boehmi in naturally infected dogs

 

Day 6/-2

Day 28

Day 56

Group 1

120.39 [0–600]

94.04 [0–300]

127.38 [0–1400]

Group 2

164.11 [0–1350]

2.36 [0–100]

0.00 [0–0]

Efficacy (P-value)

NA (NS)

97.49% (1.65 × 10−9)

100.00% (2.12 × 10−11)

  1. Group 1: dogs treated with the negative control product NEXGARD®
  2. Group 2: dogs treated with NEXGARD SPECTRA®
  3. NS Not statistically significant. [Minimum–maximum EPG values]